Serology Expansion CBL Path recently launched COVID-19 antibody testing, signaling capabilities in serology and infectious disease testing. This creates sales opportunities to offer expanded antibody panels, complementary serology services, and partnerships with hospitals and clinics needing surge or routine serology testing, with bundled reporting and specimen logistics.

Digital Workflow The company uses DocuSign and Microsoft within a security-conscious tech stack, indicating readiness for digital contracts and secure data exchange. Sales opportunities include end-to-end digital laboratory workflows, LIMS or data integration services, electronic patient consent, secure report delivery, and interoperability with customer EHR systems.

Regional Focus With a headquarters in Hicksville, NY, there is a clear regional focus that can be leveraged to secure local hospital and clinic partnerships for outsourced testing, contract lab services, and rapid turnaround territories within the Northeast.

Scale Readiness As a mid-size laboratory, there are opportunities to pitch scalable automation, workflow optimization, and analytics services to support expansion in testing capacity, efficiency, and compliance as demand grows.

Competitive Positioning Position CBL Path as a nimble partner for rapid onboarding and specialized infectious disease testing to compete with larger networks. Emphasize flexibility, pilot programs, and tailored solutions to win contracts with hospitals and regional labs.